What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Gary L. Keeney mostly deals with Internal medicine, Endometrial cancer, Surgery, Pathology and Oncology.
His work focuses on many connections between Internal medicine and other disciplines, such as Gastroenterology, that overlap with his field of interest in Endometrium and Carcinoma.
His Endometrial cancer research integrates issues from Hysterectomy, Lymphadenectomy, Primary tumor, Metastasis and Prospective cohort study.
His Pathology research includes themes of Chromosome 13 and Breast cancer.
The Oncology study combines topics in areas such as Odds ratio, Tissue microarray and Bioinformatics.
The various areas that Gary L. Keeney examines in his Stage study include Disease and Ovary.
His most cited work include:
- Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? (375 citations)
- Sentinel Lymph Node Biopsy With Metastasis: Can Axillary Dissection Be Avoided in Some Patients With Breast Cancer? (281 citations)
- Folate receptor alpha as a tumor target in epithelial ovarian cancer (278 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Internal medicine, Pathology, Endometrial cancer, Oncology and Surgery.
His study on Internal medicine is mostly dedicated to connecting different topics, such as Gastroenterology.
His work in Pathology addresses issues such as Ovary, which are connected to fields such as Disease.
His Endometrial cancer study combines topics from a wide range of disciplines, such as Hysterectomy, Lymphadenectomy, Lymph node, Metastasis and Adjuvant therapy.
His Oncology research is multidisciplinary, incorporating elements of Serous fluid, Survival analysis, Hazard ratio, Breast cancer and Tissue microarray.
His studies deal with areas such as Cohort and Urology as well as Surgery.
He most often published in these fields:
- Internal medicine (40.09%)
- Pathology (35.85%)
- Endometrial cancer (32.08%)
What were the highlights of his more recent work (between 2016-2021)?
- Internal medicine (40.09%)
- Oncology (30.66%)
- Endometrial cancer (32.08%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Endometrial cancer, Pathology and Serous fluid.
His studies link Gene expression with Internal medicine.
His Oncology study combines topics in areas such as Immunohistochemistry, Cancer research, Clinical trial, Chemotherapy and Ovarian cancer.
His biological study spans a wide range of topics, including Stage, Sentinel lymph node, Lymphadenectomy and Metastasis.
His work carried out in the field of Pathology brings together such families of science as Fluorescence in situ hybridization and Gene rearrangement.
He has researched Serous fluid in several fields, including Ovarian carcinoma and Ovarian tumor.
Between 2016 and 2021, his most popular works were:
- Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease (49 citations)
- Distinct microbes, metabolites, and ecologies define the microbiome in deficient and proficient mismatch repair colorectal cancers. (48 citations)
- Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes. (43 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Cohort, Oncology, Internal medicine, Pathology and Lymphadenectomy.
His research in Cohort intersects with topics in Immunohistochemistry, Tissue microarray and Carcinoma.
His Oncology study which covers Clinical trial that intersects with Survival analysis.
In general Internal medicine study, his work on Debulking and Cancer often relates to the realm of Subtyping, thereby connecting several areas of interest.
His work deals with themes such as Fluorescence in situ hybridization and Immunophenotyping, which intersect with Pathology.
He combines subjects such as Stage IIIC, Sentinel lymph node, Progression-free survival and Endometrial cancer with his study of Lymphadenectomy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
